• Exchange: Frankfurt
  • Sector: Health Care
  • Industry: Biotech & Pharma
  • Sub-Industry: Specialty Pharmaceuticals

OFK:GR

21.930 EUR 0.144 0.66%

As of 03:06:12 ET on 04/17/2014.

Snapshot for Orion OYJ (OFK)

Open: 21.925 Day's Range: 21.865 - 21.930 Volume: 0
Previous Close: 21.786 52wk Range: 17.265 - 24.670 1-Yr Rtn: +12.91%

Stock Chart for OFK

No chart data available.
  • OFK:GR 21.930
  • 1D
  • 1M
  • 1Y
21.786
Interactive OFK Chart

Previous Close

No chart data available.
Interactive Chart
  • 1D
  • 1W
  • 1M
  • YTD
  • 1Y
  • 3Y
  • 5Y
Close:
Open:
High:
Low:
Volume:
Recently Viewed Symbols
Save as Watchlist
Saving as watchlist...

Key Statistics for OFK

Current P/E Ratio (ttm) -
Estimated P/E(12/2014) 16.4516
Relative P/E vs. DAX -
Earnings Per Share (EUR) (ttm) -
Est. EPS (EUR) (12/2014) 1.3330
Est. PEG Ratio -
Market Cap (M EUR) 3,076.62
Shares Outstanding (M) 99.54
30 Day Average Volume 310
Price/Book (mrq) -
Price/Sale (ttm) -
Dividend Indicated Gross Yield 5.71%
Cash Dividend (EUR) 1.2500
Dividend Ex-Date 03/26/2014
5 Year Dividend Growth 5.64%
Next Earnings Announcement 04/29/2014
mrq = Most Recent Quarter; ttm = Trailing Twelve Months

Income Statement for OFK

  • Revenue
  • Net Income (M/EUR)
  • Profit Margin (%)

Company Profile & Key Executives for OFK

Orion Oyj develops and manufactures pharmaceuticals and diagnostic kits. The Company produces hormone therapies and drugs to treat central nervous system disorders, cardiovascular diseases and urological disorders, and in vitro diagnostic kits used in doctor's offices and small laboratories.

Hannu SyrjaenenChairmanJukka YlppoVice Chairman
Timo LappalainenPresident/CEOJari KarlsonChief Financial Officer
More Company Profile & Key Executives for OFK

Quotes delayed, except where indicated otherwise. All prices in local currency. Time is ET.

Advertisement
Advertisement
Sponsored Links
Advertisements
sec ||= nil